Civic IQ
RESEARCH_GRANTONGOING

OHSU Board of Directors Agenda Packet January 2026

George Washington University Sponsors Immunology Research at ONPRC

$2,878,144 (SIV Elite Controller Cohort genetic analysis), $1,408,802 (Antibody treatment for dengue fever), $105,357 (Maternal-fetal interface project)Oregon Health & Science UniversityGEORGE WASHINGTON UNIVERSITYJanuary 22, 2026

Trusted by teams at

Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo

Description

George Washington University funds interdisciplinary research at ONPRC on SIV elite controllers and dengue therapy, with projects concluding between 2026 and 2029.

Contract Details

Contract Amount

$2,878,144 (SIV Elite Controller Cohort genetic analysis), $1,408,802 (Antibody treatment for dengue fever), $105,357 (Maternal-fetal interface project)

Vendor

GEORGE WASHINGTON UNIVERSITY

Agency

Oregon Health & Science University, OR

Contract Type

RESEARCH_GRANT

Document Date

January 22, 2026

Contract Term

Project end dates: 08/31/26, 04/20/26, 05/31/29

Renewal Date

2029-05-31

Renewal Info

Grants specified per project timeline; renewals subject to new funding cycles.

Bring us your territory.
We'll show you what is forming.

See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.

Try Civic IQ for free